Experimental neurology
Daily intranasal resveratrol-conjugated gold nanoparticles administration promotes neuroprotection and improves neurological outcome in the R6/2 mouse model of Huntington's disease.
Emanuela Paldino, Emiliano Montalesi, Marco Fiocchetti, Flavia Dioguardi, Iole Venditti, Elena Olivieri, Maria Marino, Francesca R Fusco
Published: 202610.1016/j.expneurol.2026.115639
Abstract
Pan-apoptosis and involvement of the inflammatory process are the hallmarks of Huntington's disease (HD). Inflammation currently represents one of the potential therapeutic targets for slowing and fighting the pathological phenotype of HD. The immuno…
Preview only. Read the full abstract at the source